Blog

Home » Blog

Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival

Hormone Therapy / By / / 1 minute of reading

Adding abiraterone acetate (Zytiga) plus prednisone to standard hormonal therapy for men newly diagnosed with high-risk, metastatic prostate cancer lowers the chance of death by 38%. In a phase III clinical trial of 1,200 men, abiraterone also more than doubled the median time until the cancer worsened, from 14.8 months to 33 months. Read the article here.

Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival Read More »

New IsoPSA assay detects prostate cancer more precisely than current tests

PSA Screening, Diagnosis / By / / 1 minute of reading

A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease. Read the article here.

New IsoPSA assay detects prostate cancer more precisely than current tests Read More »

Immunotherapy

Treatments / By / / 1 minute of reading

Immunotherapy is an exciting new field of study that is designed to boost the body’s immune system to fight cancer. It uses materials either made by the body or in a lab to improve, target or restore immune function. There are different types of immunotherapy including vaccines, monoclonal antibodies and non-specific immunotherapies. In prostate cancer, a treatment vaccine helps the body’s immune system fight cancer by training it to recognize and destroy cancer cells. Read the article here.

Immunotherapy Read More »

Thousands of men with prostate cancer get risky treatment they don’t need.

Diagnosis / By / / 1 minute of reading

Researchers are developing genetic tests, imaging tests, and algorithms like those in face-recognition software in an effort to reduce the 1 million US men a year who have prostate biopsies and, even more important, reduce the thousands who get treatment they don’t need. Read the article here.

Thousands of men with prostate cancer get risky treatment they don’t need. Read More »

Active Surveillance in Men under 60

Active Surveillance / By / / 1 minute of reading

Younger age at diagnosis of low-risk prostate cancer was independently associated with decreased risk of disease progression in men managed with active surveillance, researchers reported. Read the article here. Active surveillance is a reasonable option for carefully selected men under 60 with low-risk prostate cancer. However, patients must be surveyed closely and understand the significant risk of ultimately needing treatment. Read the article here.

Active Surveillance in Men under 60 Read More »

A Pooled Analysis of 15 Prospective Cohort Studies on the Association Between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer.

Diet / By / / 1 minute of reading

A study did not observe any statistically significant associations for advanced prostate cancer or prostate cancer mortality with any food group (including total fruits and vegetables, total fruits, total vegetables, fruit and vegetable juice, cruciferous vegetables, and tomato products), nor specific fruit and vegetables. Read the article here.

A Pooled Analysis of 15 Prospective Cohort Studies on the Association Between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer. Read More »

Scroll to Top